HCV Reinfection Uncommon Among People Who Inject Drugs

Reinfection rates are low after treating hepatitis C virus in people taking opioid agonist therapy (OAT), even among those who are still injecting drugs, according to a new study. The findings, which are based on prospective data from 13 countries, including the United States, and were published in Annals of Internal Medicine (2022 Aug 8. … Read more

Liver Disease a New Dementia Risk Factor?

Nonalcoholic fatty liver disease (NAFLD) is linked to an increased dementia risk, with an even greater risk in the setting of comorbid heart disease or history of stroke, new research shows. Investigators analyzed data for almost 3000 older individuals diagnosed with NAFLD and compared them with a large group of matched peers without NAFLD. At … Read more

Treatment for Alcohol Abuse Reduces Hepatitis Readmission

SAN DIEGO — Treating people with alcoholic hepatitis for alcohol abuse may reduce their risk of hospital readmission, researchers reported. In a retrospective analysis of nationwide data, 7.83% of those patients who received psychotherapy, counseling, or drug treatment for alcohol abuse were readmitted within 30 days, versus 11.67% of those who did not receive these … Read more